Cerebellar pathology in multiple sclerosis and experimental autoimmune encephalomyelitis: current status and future directions.

Cerebellum deep cerebellar nuclei experimental autoimmune encephalomyelitis multiple sclerosis neuroinflammation

Journal

Journal of central nervous system disease
ISSN: 1179-5735
Titre abrégé: J Cent Nerv Syst Dis
Pays: United States
ID NLM: 101595026

Informations de publication

Date de publication:
2023
Historique:
received: 28 05 2023
accepted: 15 10 2023
medline: 9 11 2023
pubmed: 9 11 2023
entrez: 9 11 2023
Statut: epublish

Résumé

Recent decades have witnessed significant progress in understanding mechanisms driving neurodegeneration and disease progression in multiple sclerosis (MS), but with a focus on the cerebrum. In contrast, there have been limited studies of cerebellar disease, despite the common occurrence of cerebellar symptoms in this disorder. These rare studies, however, highlight the early cerebellar involvement in disease development and an association between the early occurrence of cerebellar lesions and risk of worse prognosis. In parallel developments, it has become evident that far from being a region specialized in movement control, the cerebellum plays a crucial role in cognitive function, via circuitry connecting the cerebellum to association areas of the cerebrum. This complexity, coupled with challenges in imaging of the cerebellum have been major obstacles in the appreciation of the spatio-temporal evolution of cerebellar damage in MS and correlation with disability and progression. MS studies based on animal models have relied on an induced neuroinflammatory disease known as experimental autoimmune encephalomyelitis (EAE), in rodents and non-human primates (NHP). EAE has played a critical role in elucidating mechanisms underpinning tissue damage and been validated for the generation of proof-of-concept for cerebellar pathological processes relevant to MS. Additionally, rodent and NHP studies have formed the cornerstone of current knowledge of functional anatomy and cognitive processes. Here, we propose that improved insight into consequences of cerebellar damage in MS at the functional, cellular and molecular levels would be gained by more extensive characterization of EAE cerebellar pathology combined with the power of experimental paradigms in the field of cognition. Such combinatorial approaches would lead to improved potential for the development of MS sensitive markers and evaluation of candidate therapeutics.

Identifiants

pubmed: 37942276
doi: 10.1177/11795735231211508
pii: 10.1177_11795735231211508
pmc: PMC10629308
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

11795735231211508

Informations de copyright

© The Author(s) 2023.

Déclaration de conflit d'intérêts

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

PLoS One. 2016 Dec 1;11(12):e0167196
pubmed: 27907119
Front Immunol. 2018 Apr 23;9:835
pubmed: 29740441
Brain Pathol. 2017 Nov;27(6):737-747
pubmed: 27706868
Nat Rev Neurosci. 2010 Jan;11(1):9-17
pubmed: 20019686
Nat Rev Dis Primers. 2018 Nov 8;4(1):43
pubmed: 30410033
J Cell Sci. 1972 Mar;10(2):535-46
pubmed: 5018033
PLoS One. 2012;7(10):e45409
pubmed: 23049678
Radiology. 2018 Apr;287(1):267-275
pubmed: 29272214
Ann Neurol. 2001 Sep;50(3):389-400
pubmed: 11558796
Behav Brain Res. 2013 Oct 15;255:26-34
pubmed: 23623886
Biol Mood Anxiety Disord. 2011 Nov 07;1(1):9
pubmed: 22738250
Cold Spring Harb Perspect Med. 2018 Nov 1;8(11):
pubmed: 29311122
J Neurol Sci. 2009 Jul 15;282(1-2):47-54
pubmed: 19201003
Neurol Clin Pract. 2021 Aug;11(4):342-351
pubmed: 34476126
PLoS Genet. 2007 Apr 20;3(4):e59
pubmed: 17447843
Neuroimage. 2009 Dec;48(4):637-51
pubmed: 19589388
Nat Rev Neurol. 2017 Jan;13(1):25-36
pubmed: 27934854
EBioMedicine. 2021 Jun;68:103392
pubmed: 34044219
Sci Rep. 2019 Sep 16;9(1):13299
pubmed: 31527712
Ther Adv Neurol Disord. 2019 Apr 22;12:1756286419840593
pubmed: 31040881
Front Neurol. 2017 Jun 28;8:312
pubmed: 28701995
Brain Pathol. 2007 Jan;17(1):38-44
pubmed: 17493036
Biomedicines. 2019 Jul 29;7(3):
pubmed: 31362384
Nat Rev Neurol. 2010 Aug;6(8):438-44
pubmed: 20625376
J Neurol Neurosurg Psychiatry. 2009 Feb;80(2):182-7
pubmed: 18829630
Immunol Rev. 2001 Oct;183:159-72
pubmed: 11782255
Nat Protoc. 2013 Dec;8(12):2531-7
pubmed: 24263092
Acta Neuropathol. 2018 Jun;135(6):907-921
pubmed: 29541917
Clin Neurol Neurosurg. 2008 Mar;110(3):233-8
pubmed: 18093725
Neuroimage. 2012 Mar;60(1):95-104
pubmed: 22182769
Mult Scler Relat Disord. 2014 Sep;3(5):555-64
pubmed: 26265267
Acta Neuropathol. 2008 Mar;115(3):275-87
pubmed: 18175128
J Neuropathol Exp Neurol. 2003 Jul;62(7):723-32
pubmed: 12901699
Cerebellum Ataxias. 2018 Oct 12;5:11
pubmed: 30345063
Expert Opin Drug Discov. 2018 May;13(5):387-397
pubmed: 29465302
Cerebellum. 2015 Feb;14(1):19-22
pubmed: 25326653
Brain Pathol. 2017 Mar;27(2):123-137
pubmed: 27792289
Ann Neurol. 2021 Sep;90(3):440-454
pubmed: 34231919
Curr Biol. 2017 Apr 24;27(8):1249-1250
pubmed: 28441555
BMC Neurol. 2018 Mar 9;18(1):27
pubmed: 29523094
Sci Rep. 2019 Jun 11;9(1):8488
pubmed: 31186441
Neurosci Res. 2020 Mar;152:44-58
pubmed: 31857115
Microsc Res Tech. 1995 Oct 15;32(3):230-45
pubmed: 8527857
Nat Protoc. 2007;2(2):322-8
pubmed: 17406592
Int J Mol Sci. 2020 Jun 17;21(12):
pubmed: 32560364
eNeurologicalSci. 2017 May 13;7:37-43
pubmed: 29260023
J Clin Exp Neuropsychol. 2012;34(1):35-56
pubmed: 22047489
J Neurol Neurosurg Psychiatry. 2010 Apr;81(4):401-4
pubmed: 19965849
Nat Rev Neurosci. 2005 Apr;6(4):297-311
pubmed: 15803161
Ann Neurol. 2004 Apr;55(4):458-68
pubmed: 15048884
Neurosci Biobehav Rev. 2018 Jun;89:85-98
pubmed: 29477616
Neuropathol Appl Neurobiol. 2015 Oct;41(6):798-813
pubmed: 25421634
Curr Opin Pharmacol. 2018 Feb;38:16-23
pubmed: 29471184
Mult Scler. 2006 Dec;12(6):775-81
pubmed: 17263006
J Neurol Neurosurg Psychiatry. 1999 Aug;67(2):153-7
pubmed: 10406980
Pharmacol Biochem Behav. 2000 Nov;67(3):587-96
pubmed: 11164090
J Neuropathol Exp Neurol. 2018 Jul 1;77(7):567-576
pubmed: 29757405
J Neurol. 2023 Nov;270(11):5235-5250
pubmed: 37639018
Ann Clin Transl Neurol. 2015 May;2(5):581-93
pubmed: 26000330
J Neurosci Methods. 1985 Aug;14(3):149-67
pubmed: 2864480
PLoS One. 2014 May 02;9(5):e96193
pubmed: 24789257
Front Immunol. 2017 Apr 18;8:425
pubmed: 28458668
Proc Natl Acad Sci U S A. 2000 Oct 10;97(21):11598-602
pubmed: 11027357
Neuroimage Clin. 2013 Nov 27;4:130-8
pubmed: 24371795
AJNR Am J Neuroradiol. 2017 Aug;38(8):1467-1474
pubmed: 28408628
Brain Pathol. 2015 Nov;25(6):692-700
pubmed: 25411024
Autoimmunity. 2015 Jun;48(4):208-21
pubmed: 25427822
Neurosci Biobehav Rev. 2021 Jan;120:1-12
pubmed: 33242563
J Neuroimmune Pharmacol. 2013 Dec;8(5):1251-64
pubmed: 23821341
Proc Natl Acad Sci U S A. 2014 Jan 14;111(2):823-8
pubmed: 24297904
Brain. 2006 Aug;129(Pt 8):1972-83
pubmed: 16714315
J Clin Med. 2019 Feb 01;8(2):
pubmed: 30717130
Nat Rev Neurol. 2016 Jun;12(6):358-68
pubmed: 27125632
Neuron. 2013 Oct 30;80(3):807-15
pubmed: 24183029
Cerebellum. 2015 Jun;14(3):364-74
pubmed: 25578034
Mult Scler. 2011 Oct;17(10):1155-61
pubmed: 21613334
Curr Opin Neurol. 2020 Jun;33(3):277-285
pubmed: 32324705
Nat Rev Neurosci. 2006 Jul;7(7):511-22
pubmed: 16791141
Front Neurol. 2020 Jun 30;11:529
pubmed: 32695059
Radiology. 2014 Jun;271(3):822-30
pubmed: 24555637
Cerebellum Ataxias. 2016 May 03;3:9
pubmed: 27144010
Nat Rev Neurosci. 2012 Jun 20;13(7):507-14
pubmed: 22714021
Cerebellum. 2017 Apr;16(2):552-576
pubmed: 27485952
World J Radiol. 2017 Oct 28;9(10):371-388
pubmed: 29104740
Mult Scler. 2006 Aug;12(4):369-74
pubmed: 16900750
J Neurol. 2018 Oct;265(10):2260-2266
pubmed: 30056570
J Neurophysiol. 2018 Dec 1;120(6):2707-2709
pubmed: 30110238
J Neurosci Res. 2018 Jun;96(6):1021-1042
pubmed: 29446144
Mult Scler. 2020 May;26(6):668-678
pubmed: 30973800
Front Immunol. 2019 Jan 10;9:3116
pubmed: 30687321
Brain. 2005 Nov;128(Pt 11):2713-21
pubmed: 16150849
Ann Neurol. 2000 Jun;47(6):707-17
pubmed: 10852536
Brain. 2005 Nov;128(Pt 11):2705-12
pubmed: 16230320
Front Neurol. 2020 Aug 28;11:784
pubmed: 32982904
Immunol Today. 2000 Jun;21(6):290-7
pubmed: 10825741
Front Immunol. 2021 Feb 19;12:620963
pubmed: 33679764
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):18980-4
pubmed: 23112179
J Neurol. 2021 Dec;268(12):4587-4593
pubmed: 33083867
Neurorehabil Neural Repair. 2022 Feb;36(2):103-106
pubmed: 34931569
Mult Scler. 2011 Jun;17(6):647-57
pubmed: 21372117
N Engl J Med. 2011 Dec 8;365(23):2188-97
pubmed: 22150037
Curr Pharm Des. 2015;21(18):2440-52
pubmed: 25777759
Ther Adv Neurol Disord. 2013 Jul;6(4):237-48
pubmed: 23858327
Brain Pathol. 2020 May;30(3):641-652
pubmed: 31916298
Brain. 2023 Jun 1;146(6):2316-2331
pubmed: 36448302
Front Immunol. 2021 Jun 10;12:639650
pubmed: 34177891
Science. 2019 Sep 27;365(6460):
pubmed: 31604244
Int MS J. 2009 Jun;16(2):57-65
pubmed: 19671369
Cerebellum. 2022 Dec;21(6):1052-1060
pubmed: 34657272
Radiology. 2013 Jul;268(1):181-9
pubmed: 23533287
CNS Drugs. 2014 Feb;28(2):147-56
pubmed: 24446248
Cold Spring Harb Perspect Med. 2019 Apr 1;9(4):
pubmed: 29661809
Neurobiol Learn Mem. 2019 Feb 13;:106996
pubmed: 30771461
Drug Discov Today. 2016 Aug;21(8):1200-5
pubmed: 27060373
Cereb Cortex. 2021 Jan 1;31(1):439-447
pubmed: 32901254
Neuroimage. 2006 Sep;32(3):1016-23
pubmed: 16806982
Lancet Neurol. 2010 May;9(5):520-32
pubmed: 20398859
Trends Neurosci. 2005 Apr;28(4):173-5
pubmed: 15808350
Acta Neuropathol. 2000 Aug;100(2):174-82
pubmed: 10963365
Mult Scler. 2009 Jul;15(7):811-7
pubmed: 19465449
Front Mol Neurosci. 2022 Oct 19;15:1024058
pubmed: 36340686
Mult Scler Relat Disord. 2019 May;30:215-224
pubmed: 30822617
J Neurol Neurosurg Psychiatry. 2004 Jun;75(6):840-6
pubmed: 15145996
Curr Opin Neurobiol. 2018 Feb;48:146-152
pubmed: 29316490
Cold Spring Harb Perspect Med. 2018 Sep 4;8(9):
pubmed: 29358317
Neuroreport. 2003 Mar 24;14(4):555-8
pubmed: 12657884
Mult Scler. 2016 Jan;22(1):73-84
pubmed: 25921041
Int J Mol Sci. 2015 May 28;16(6):12185-98
pubmed: 26030676
Brain. 1995 Dec;118 ( Pt 6):1583-92
pubmed: 8595487
Cerebellum. 2002 Jan-Mar;1(1):57-68
pubmed: 12879974
J Neurol Sci. 1973 Sep;20(1):73-83
pubmed: 4744512
Mult Scler Relat Disord. 2018 Oct;25:29-36
pubmed: 30029018

Auteurs

Dain L Maxwell (DL)

Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, Australia.
Department of Anatomy and Neuroscience, The University of Melbourne, Parkville, VIC, Australia.

Jacqueline M Orian (JM)

Department of Biochemistry and Chemistry, La Trobe Institute for Molecular Science, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, VIC, Australia.

Classifications MeSH